Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related LHCG
Top Performing Industries For July 6, 2015
Top Performing Industries For June 25, 2015
Related GEVA
Ultragenyx Downgraded At Morgan Stanley, Valuation 'Stretched' And Pipeline Faces Execution Risk
JMP Starts Ultragenyx At Outperform, Pipeline Maturity Expected To Continue

Analysts at Deutsche Bank downgraded LHC Group (NASDAQ: LHCG) from “buy” to “hold.” The target price for LHC Group is set to $23. LHC Group's shares closed at $23.36 yesterday.

Analysts at JP Morgan downgraded Synageva BioPharma (NASDAQ: GEVA) from “overweight” to “neutral.” The target price for Synageva BioPharma has been lowered from $57 to $50. Synageva BioPharma's shares closed at $45.79 yesterday.

Analysts at Canaccord Genuity downgraded Rent-A-Center (NASDAQ: RCII) from “buy” to “hold.” The target price for Rent-A-Center has been lowered from $42.00 to $37.00. Rent-A-Center's shares closed at $35.80 yesterday.

McNicoll Lewis Vlak downgraded Transcept Pharmaceuticals (NASDAQ: TSPT) from “buy” to “hold.” The target price for Transcept Pharmaceuticals is set to $3. Transcept Pharmaceuticals' shares closed at $3.09 yesterday.

Latest Ratings for LHCG

DateFirmActionFromTo
Aug 2015OppenheimerMaintainsOutperform
Feb 2015Credit SuisseMaintainsOutperform
Dec 2014Credit SuisseUpgradesUnderperformOutperform

View More Analyst Ratings for LHCG
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (LHCG + GEVA)

View Comments and Join the Discussion!

Get Benzinga's Newsletters